HomeCLN • WSE
add
Celon Pharma SA
Previous close
zł 16.64
Day range
zł 16.38 - zł 16.90
Year range
zł 13.94 - zł 17.94
Market cap
859.79M PLN
Avg Volume
38.82K
P/E ratio
-
Dividend yield
-
Primary exchange
WSE
Market news
Financials
Income Statement
Revenue
Net income
(PLN) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 54.05M | -1.01% |
Operating expense | 47.65M | 12.43% |
Net income | -14.97M | -24.90% |
Net profit margin | -27.69 | -26.15% |
Earnings per share | — | — |
EBITDA | -233.00K | 96.13% |
Effective tax rate | -102.01% | — |
Balance Sheet
Total assets
Total liabilities
(PLN) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 114.54M | -30.42% |
Total assets | 569.31M | -11.43% |
Total liabilities | 123.75M | -24.13% |
Total equity | 445.56M | — |
Shares outstanding | 51.06M | — |
Price to book | 1.91 | — |
Return on assets | -4.20% | — |
Return on capital | -5.07% | — |
Cash Flow
Net change in cash
(PLN) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -14.97M | -24.90% |
Cash from operations | 7.41M | -67.05% |
Cash from investing | 3.40M | 125.73% |
Cash from financing | -371.00K | 91.13% |
Net change in cash | 10.44M | 105.07% |
Free cash flow | -484.62K | -103.09% |
About
Founded
2002
Website
Employees
513